NKMax Rebrands As NKGen Ahead of Next Clinical Trial Launch, Off-The-Shelf Testing Days after announcing the U.S. Food and Drug Administration (FDA) has cleared the next clinical trials to launch for its lead natural killer (NK) cell therapies, NKMax America announced it has renamed itself NKGen Biotech to better align with its core focus and […]
Read More
Melphalan Market 2021 – Suitable Circumstance Global Melphalan Industry: with growing significant CAGR during 2021-2026 New Research Report on Melphalan Market which covers Market Overview, Future Economic Impact, Competition by Manufacturers, Supply (Production), and Consumption Analysis Understand the influence of COVID-19 on the Melphalan Market with our analysts monitoring the situation across the globe. Request […]
Read More
Conversation with The Cancer Letter publication date: Apr. 2, 2021 Issue 13 – Apr. 2, 2021 To access this members-only content, please log in.Institutional subscribers, please log in with your IP.If you’re not a subscriber why not join today? To gain access to the members only content click here to subscribe.You will be given immediate […]
Read More
Research finds possible explanation for why many cancer drugs don’t work in human trials A possible explanation for why many cancer drugs that kill tumor cells in mouse models won’t work in human trials has been found by researchers with The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics and […]
Read More
Study finds why some cancer drugs may be ineffective Washington [US], April 1 (ANI): A possible explanation for why many cancer drugs that kill tumor cells in mouse models won’t work in human trials has been found by researchers with The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics and […]
Read More
Stem cell transplants offer long-term benefits for pediatric cancer patients receiving immunotherapy Children and young adults who receive CAR T-cell therapy for the most common childhood cancer – acute lymphoblastic leukemia – suffer remarkably fewer relapses and are far more likely to survive when the treatment is paired with a subsequent stem cell transplant, a […]
Read More
A Look Back at the FDA News from March 2020 During March 2021, the FDA granted approval to 9 therapies and 1 assay across the fields of lung cancer, lymphoma, renal cell carcinoma, and gastrointestinal cancers, and more. One prospective approval chronic graft-versus-host disease was postponed by the FDA during March. Still, countless agents were […]
Read More ”; Adding content on business industry: In the corporate sector, there are a wide range of industries out of which you can use for research. Various options available include sectors like airline, automobile, data warehousing, footwear, fashion industry, and television and advertising among others. To make it voluminous, students should add various case studies related […]
Read More Worse cancer outcomes in areas of deprivation transcend access to quality care [unable to retrieve full-text content] medwireNews: Researchers have identified an association between socioeconomic deprivation and poor survival in people with cancer participating …Published at Wed, 31 Mar 2021 15:22:25 +0000
Read More
Quality of Life on Cancer Drugs ― Still Largely a Mystery Just a 20-minute walk from the Leiden University Medical Center, in Leiden, the Netherlands, is a two-story mural by the American poet e.e. cummings. A fragment reads: “the city sleeps with death upon her mouth having a song in her eyes.” The poem, included […]
Read More